Exosomes Market 2027 By Product and Service, Type, Application and Geography | The Insight Partners

Exosomes Market to 2027 - Global Analysis and Forecasts By Product and Service (Kits and Reagents, Instruments, Services); Type (Non-Coding RNAs, mRNA, Proteins, DNA Fragments, Lipids); Application (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases) and Geography

Report Code: TIPRE00004909 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Exosome therapy is the new treatment accept by the doctor and it is used to early stage of cancer detection. Exosome therapy is important then stem cell due to their unique ability to function as a messenger with the body transferring information from cell to cell. Exosomal RNA as bio-marker and therapeutic potential of exosome vector exosome contain protein, micro-RNA, mRNA that can be transferred between cell.

MARKET DYNAMICS
The exosomes market is expected to grow during the forecast period owing to the key driving factors such as rising healthcare expenditure, increase prevalence of cancer, raising emphasis on early diagnosis of cancer, increase oncology research, awareness related to healthcare and others. In addition, various players in the emerging market have strong pipeline product and high potential which are anticipated to create several growth opportunities for the market during the forecast period.

MARKET SCOPE
The "Global Exosomes Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of exosomes with detailed market segmentation by products and services, type, application and geography. The global exosomes market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the exosomes market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global exosomes market is segmented on the basis of product and services, type and application. Based on products and services, the market is segmented as Kits and Reagents, instruments and services. On the basis of type, the global exosomes market is segmented into non-coding RNAs, mRNA, proteins, DNA fragments and lipids. Based on the application the market is segmented into cancer, neurodegenerative diseases, cardiovascular diseases and infectious diseases.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global exosomes market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The exosomes market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting exosomes market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the exosomes market in these regions.

MARKET PLAYERS
The reports cover key developments in the exosomes market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from exosomes market are anticipated to lucrative growth opportunities in the future with the rising demand for exosomes market in the global market. Below mentioned is the list of few companies engaged in the exosomes market.

The report also includes the profiles of key exosomes market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Takara Bio Company
  • Illumina, Inc
  • Thermo Fisher Scientific, Inc
  • Codiak BioSciences
  • Evox Therapeutics Limited
  • HansaBioMed Life Sciences
  • System Biosciences, LLC
  • Lonza
  • Norgen Biotek Corp
  • Miltenyi Biotec
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Exosomes Market - By Product and Service
1.3.2 Exosomes Market - By Type
1.3.3 Exosomes Market - By Application
1.3.4 Exosomes Market - By Region
1.3.4.1 by Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EXOSOMES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. EXOSOMES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EXOSOMES MARKET - GLOBAL MARKET ANALYSIS
6.1. EXOSOMES - GLOBAL MARKET OVERVIEW
6.2. EXOSOMES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. EXOSOMES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT AND SERVICE
7.1. OVERVIEW
7.2. PRODUCT AND SERVICE MARKET FORECASTS AND ANALYSIS
7.3. KITS AND REAGENTS
7.3.1. Overview
7.3.2. Kits and Reagents Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.5. SERVICES
7.5.1. Overview
7.5.2. Services Market Forecast and Analysis
8. EXOSOMES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. NON-CODING RNAS
8.3.1. Overview
8.3.2. Non-Coding RNAs Market Forecast and Analysis
8.4. MRNA
8.4.1. Overview
8.4.2. mRNA Market Forecast and Analysis
8.5. PROTEINS
8.5.1. Overview
8.5.2. Proteins Market Forecast and Analysis
8.6. DNA FRAGMENTS
8.6.1. Overview
8.6.2. DNA Fragments Market Forecast and Analysis
8.7. LIPIDS
8.7.1. Overview
8.7.2. Lipids Market Forecast and Analysis
9. EXOSOMES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CANCER
9.3.1. Overview
9.3.2. Cancer Market Forecast and Analysis
9.4. NEURODEGENERATIVE DISEASES
9.4.1. Overview
9.4.2. Neurodegenerative Diseases Market Forecast and Analysis
9.5. CARDIOVASCULAR DISEASES
9.5.1. Overview
9.5.2. Cardiovascular Diseases Market Forecast and Analysis
9.6. INFECTIOUS DISEASES
9.6.1. Overview
9.6.2. Infectious Diseases Market Forecast and Analysis
10. EXOSOMES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Exosomes Market Overview
10.1.2 North America Exosomes Market Forecasts and Analysis
10.1.3 North America Exosomes Market Forecasts and Analysis - By Product and Service
10.1.4 North America Exosomes Market Forecasts and Analysis - By Type
10.1.5 North America Exosomes Market Forecasts and Analysis - By Application
10.1.6 North America Exosomes Market Forecasts and Analysis - By Countries
10.1.6.1 United States Exosomes Market
10.1.6.1.1 United States Exosomes Market by Product and Service
10.1.6.1.2 United States Exosomes Market by Type
10.1.6.1.3 United States Exosomes Market by Application
10.1.6.2 Canada Exosomes Market
10.1.6.2.1 Canada Exosomes Market by Product and Service
10.1.6.2.2 Canada Exosomes Market by Type
10.1.6.2.3 Canada Exosomes Market by Application
10.1.6.3 Mexico Exosomes Market
10.1.6.3.1 Mexico Exosomes Market by Product and Service
10.1.6.3.2 Mexico Exosomes Market by Type
10.1.6.3.3 Mexico Exosomes Market by Application
10.2. EUROPE
10.2.1 Europe Exosomes Market Overview
10.2.2 Europe Exosomes Market Forecasts and Analysis
10.2.3 Europe Exosomes Market Forecasts and Analysis - By Product and Service
10.2.4 Europe Exosomes Market Forecasts and Analysis - By Type
10.2.5 Europe Exosomes Market Forecasts and Analysis - By Application
10.2.6 Europe Exosomes Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Exosomes Market
10.2.6.1.1 Germany Exosomes Market by Product and Service
10.2.6.1.2 Germany Exosomes Market by Type
10.2.6.1.3 Germany Exosomes Market by Application
10.2.6.2 France Exosomes Market
10.2.6.2.1 France Exosomes Market by Product and Service
10.2.6.2.2 France Exosomes Market by Type
10.2.6.2.3 France Exosomes Market by Application
10.2.6.3 Italy Exosomes Market
10.2.6.3.1 Italy Exosomes Market by Product and Service
10.2.6.3.2 Italy Exosomes Market by Type
10.2.6.3.3 Italy Exosomes Market by Application
10.2.6.4 Spain Exosomes Market
10.2.6.4.1 Spain Exosomes Market by Product and Service
10.2.6.4.2 Spain Exosomes Market by Type
10.2.6.4.3 Spain Exosomes Market by Application
10.2.6.5 United Kingdom Exosomes Market
10.2.6.5.1 United Kingdom Exosomes Market by Product and Service
10.2.6.5.2 United Kingdom Exosomes Market by Type
10.2.6.5.3 United Kingdom Exosomes Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Exosomes Market Overview
10.3.2 Asia-Pacific Exosomes Market Forecasts and Analysis
10.3.3 Asia-Pacific Exosomes Market Forecasts and Analysis - By Product and Service
10.3.4 Asia-Pacific Exosomes Market Forecasts and Analysis - By Type
10.3.5 Asia-Pacific Exosomes Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Exosomes Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Exosomes Market
10.3.6.1.1 Australia Exosomes Market by Product and Service
10.3.6.1.2 Australia Exosomes Market by Type
10.3.6.1.3 Australia Exosomes Market by Application
10.3.6.2 China Exosomes Market
10.3.6.2.1 China Exosomes Market by Product and Service
10.3.6.2.2 China Exosomes Market by Type
10.3.6.2.3 China Exosomes Market by Application
10.3.6.3 India Exosomes Market
10.3.6.3.1 India Exosomes Market by Product and Service
10.3.6.3.2 India Exosomes Market by Type
10.3.6.3.3 India Exosomes Market by Application
10.3.6.4 Japan Exosomes Market
10.3.6.4.1 Japan Exosomes Market by Product and Service
10.3.6.4.2 Japan Exosomes Market by Type
10.3.6.4.3 Japan Exosomes Market by Application
10.3.6.5 South Korea Exosomes Market
10.3.6.5.1 South Korea Exosomes Market by Product and Service
10.3.6.5.2 South Korea Exosomes Market by Type
10.3.6.5.3 South Korea Exosomes Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Exosomes Market Overview
10.4.2 Middle East and Africa Exosomes Market Forecasts and Analysis
10.4.3 Middle East and Africa Exosomes Market Forecasts and Analysis - By Product and Service
10.4.4 Middle East and Africa Exosomes Market Forecasts and Analysis - By Type
10.4.5 Middle East and Africa Exosomes Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Exosomes Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Exosomes Market
10.4.6.1.1 South Africa Exosomes Market by Product and Service
10.4.6.1.2 South Africa Exosomes Market by Type
10.4.6.1.3 South Africa Exosomes Market by Application
10.4.6.2 Saudi Arabia Exosomes Market
10.4.6.2.1 Saudi Arabia Exosomes Market by Product and Service
10.4.6.2.2 Saudi Arabia Exosomes Market by Type
10.4.6.2.3 Saudi Arabia Exosomes Market by Application
10.4.6.3 U.A.E Exosomes Market
10.4.6.3.1 U.A.E Exosomes Market by Product and Service
10.4.6.3.2 U.A.E Exosomes Market by Type
10.4.6.3.3 U.A.E Exosomes Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Exosomes Market Overview
10.5.2 South and Central America Exosomes Market Forecasts and Analysis
10.5.3 South and Central America Exosomes Market Forecasts and Analysis - By Product and Service
10.5.4 South and Central America Exosomes Market Forecasts and Analysis - By Type
10.5.5 South and Central America Exosomes Market Forecasts and Analysis - By Application
10.5.6 South and Central America Exosomes Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Exosomes Market
10.5.6.1.1 Brazil Exosomes Market by Product and Service
10.5.6.1.2 Brazil Exosomes Market by Type
10.5.6.1.3 Brazil Exosomes Market by Application
10.5.6.2 Argentina Exosomes Market
10.5.6.2.1 Argentina Exosomes Market by Product and Service
10.5.6.2.2 Argentina Exosomes Market by Type
10.5.6.2.3 Argentina Exosomes Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. EXOSOMES MARKET, KEY COMPANY PROFILES
12.1. TAKARA BIO COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ILLUMINA, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CODIAK BIOSCIENCES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. EVOX THERAPEUTICS LIMITED
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HANSABIOMED LIFE SCIENCES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SYSTEM BIOSCIENCES, LLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LONZA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NORGEN BIOTEK CORP
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MILTENYI BIOTEC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Takara Bio Company
2. Illumina, Inc
3. Thermo Fisher Scientific, Inc
4. Codiak BioSciences
5. Evox Therapeutics Limited
6. HansaBioMed Life Sciences
7. System Biosciences, LLC
8. Lonza
9. Norgen Biotek Corp
10. Miltenyi Biotec